Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/19/2009 | WO2009021908A2 Disposable enzymatic sensor for liquid samples |
02/19/2009 | WO2009021907A1 Disposable sensor for liquid samples |
02/19/2009 | WO2009021600A1 Detection of the human vascular endothelial growth factor |
02/19/2009 | WO2009021551A1 A method for assessing the risk of toxicity in a chemotherapy |
02/19/2009 | WO2009021360A1 Gelsolin binding agent compositions and uses of same |
02/19/2009 | WO2009021322A1 Tumor cell-derived microvesicles |
02/19/2009 | WO2009021293A1 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity |
02/19/2009 | WO2009021269A1 Measurement of sequestered carbon |
02/19/2009 | WO2009006643A8 Measurement of protein using inclusion body dry weight |
02/19/2009 | WO2009005536A3 Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria |
02/19/2009 | WO2009004041A3 Colorimetric assay for the visual detection of primary and secondary amines |
02/19/2009 | WO2008157299A9 Differential expression profiling analysis of cell culture phenotypes and uses thereof |
02/19/2009 | WO2008156629A3 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
02/19/2009 | WO2008156493A3 Integrated quartz biological sensor and method |
02/19/2009 | WO2008155778A3 Assay for detection of transient intracellular ca2+ |
02/19/2009 | WO2008154221A3 Modulation of chemosensory receptors and ligands associated therewith |
02/19/2009 | WO2008151200A3 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets |
02/19/2009 | WO2008151089A3 Fluorescent phospholipase a2 indicators |
02/19/2009 | WO2008150496A3 Assay for sensitivity to chemotherapeutic agents |
02/19/2009 | WO2008145401A3 Mutated parvovirus structural proteins as vaccines |
02/19/2009 | WO2008140463A3 Biomarker panels for assessing radiation injury and exposure |
02/19/2009 | WO2008127789A3 Molecule attachment to nanoparticles |
02/19/2009 | WO2008127285A3 Target peptides for ovarian cancer immunotherapy |
02/19/2009 | WO2008125667A3 Screening for bone anabolic factors |
02/19/2009 | WO2008106694A3 Systems, methods and compositions for optical stimulation of target cells |
02/19/2009 | WO2008100340A3 Compositions and methods for tissue-based protein truncation test for disease diagnosis |
02/19/2009 | WO2008095462A3 Device and method for detecting the wear of an implant material and correspondingly produced implant |
02/19/2009 | WO2008044038A3 Conjugates for use in analite detection |
02/19/2009 | WO2007124105A4 Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents |
02/19/2009 | WO2007104511A8 Cancer vaccine |
02/19/2009 | WO2007084585A3 Non-human primate embryonic stem and germ cells: methods of use and methods of making same |
02/19/2009 | WO2005003311A3 Enzymes for starch processing |
02/19/2009 | US20090049561 Non-human animal exhibiting bone metastasis of tumor cells |
02/19/2009 | US20090048805 Particle Imaging Systems and Methods Using Acoustic Radiation Pressure |
02/19/2009 | US20090048786 Method for Alcohol Content Determination |
02/19/2009 | US20090048785 Methods And Systems For Analyzing Biological Samples |
02/19/2009 | US20090048324 Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules |
02/19/2009 | US20090048293 Methods for treating bacillus infection |
02/19/2009 | US20090048288 Method of treating stress-mediated depression |
02/19/2009 | US20090048200 GPR 26 G-Protein Coupled Receptor |
02/19/2009 | US20090048196 Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions |
02/19/2009 | US20090048178 Lps or lipid a binding agent and novel peptide |
02/19/2009 | US20090048176 Antibacterial agent |
02/19/2009 | US20090048173 Use Of Dipyridamole For Treatment Of Resistance To Platelet Inhibitors |
02/19/2009 | US20090048170 Target for anti-angiogenesis therapy |
02/19/2009 | US20090048168 Inhibitors of bcl-2 |
02/19/2009 | US20090048164 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
02/19/2009 | US20090048161 Cytokine receptor modulators and uses thereof |
02/19/2009 | US20090048159 Kit for treating a health condition by inducing translocation of a calreticulin protein to a cellular membrane |
02/19/2009 | US20090048150 Materials and Methods for the Detection of Nitrated Fibrinogen |
02/19/2009 | US20090048146 Use of agents that upregulate crystallin expression in the retina and optic nerve head |
02/19/2009 | US20090048121 Screening Method for the Early Diagnosis of Cerebral Vasospasm |
02/19/2009 | US20090048117 Modulation of immune system function by modulation of polypeptide arginine methyltransferases |
02/19/2009 | US20090047753 Scaffold-organized clusters and electronic devices made using such clusters |
02/19/2009 | US20090047746 Analytical Method and Analytical Apparatus |
02/19/2009 | US20090047744 Method for Improving the Characterisation of a Polynucleotide Sequence |
02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
02/19/2009 | US20090047736 Human T1R2 nucleic acid sequences and polypeptides |
02/19/2009 | US20090047696 Detection of infectious prion protein by seeded conversion of recombinant prion protein |
02/19/2009 | US20090047695 Microdevices for high-throughput screening of biomolecules |
02/19/2009 | US20090047694 Clinical Intervention Directed Diagnostic Methods |
02/19/2009 | US20090047692 Optically-detectable enzyme substrates and their method of use |
02/19/2009 | US20090047691 Method for detecting a microorganism in a liquid sample |
02/19/2009 | US20090047690 for identifying and counting lymphocytes in a biological sample such as whole blood, by means of a probe comprising a binding compound specific for a T lymphocyte-specific marker, e.g. a CD2 or CD3, and a binding compound specific for CD45RA; without the need of light scatter-based measurements |
02/19/2009 | US20090047689 Autoantigen biomarkers for early diagnosis of lung adenocarcinoma |
02/19/2009 | US20090047688 Reagents, kits and methods for detecting biological molecules by energy transfer from an activated chemiluminescent substrate to an energy acceptor dye |
02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
02/19/2009 | US20090047686 Methods for identifying and producing specific amino acid dependent antibodies and uses thereof |
02/19/2009 | US20090047685 Ultrahighly sensitive determination reagent for c-reactive protein and determination method |
02/19/2009 | US20090047684 Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan |
02/19/2009 | US20090047683 Have negatively charged substituent for fluorescent staining of DNA; used to distinguish DNA present in a sample from RNA |
02/19/2009 | US20090047682 Method of detecting and predicting bronchodilatory response to beta agonist |
02/19/2009 | US20090047676 System and method for obtaining and maintaining high-resistance seals in patch clamp recordings |
02/19/2009 | US20090047668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
02/19/2009 | US20090047660 Antibodies for oncogenic strains of HPV and methods of their use |
02/19/2009 | US20090047656 Molecular analysis of primary cells |
02/19/2009 | US20090047654 Polymer affinity matrix, a method for the production and use thereof |
02/19/2009 | US20090047356 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports; antitumor agents; kits |
02/19/2009 | US20090047344 Formulations |
02/19/2009 | US20090047300 Blood-brain barrier epitopes and uses thereof |
02/19/2009 | US20090047290 Monoclonal antibodies against beta3 integrins |
02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
02/19/2009 | US20090047282 Prophylactic/Therapeutic Agent for Cancer |
02/19/2009 | US20090047277 Recombinant il-9 antibodies and uses thereof |
02/19/2009 | US20090047274 Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases |
02/19/2009 | US20090047263 Nuclear reprogramming factor and induced pluripotent stem cells |
02/19/2009 | US20090047246 Novel inhibitors of hepatitis c virus replication |
02/19/2009 | US20090047221 Compounds and compositions useful in the treatment of neoplasia |
02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
02/19/2009 | US20090047213 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
02/19/2009 | US20090047211 Anti-mesothelin antibodies useful for immunological assays |
02/19/2009 | US20090047181 Determining fluid chemistry of formation fluid by downhole reagent injection spectral analysis |
02/19/2009 | US20090047177 Lactate concentration measurement device |
02/19/2009 | US20090045341 Systems for observing reactions using infrared imaging |
02/19/2009 | US20090045076 System and method for analyte measurement using dose sufficiency electrodes |
02/19/2009 | US20090044643 Method for Determining the Percentage of Allergens Picked Up From a Surface |
02/19/2009 | US20090044605 Device for leaching extraction and assessment |
02/19/2009 | US20090044604 Portable Measuring Facility for Determining A Medically Significant Analyte Concentration |
02/19/2009 | US20090044603 Article, device, and method |
02/19/2009 | US20090044597 Breath sampling device |